Related Experiment Video
Updated: Aug 23, 2026

A Method for Evaluating the Reinforcing Properties of Ethanol in Rats without Water Deprivation, Saccharin Fading or Extended Access Training
Published on: January 29, 2017
Use of the SF-36 in the evaluation of a drug detoxification program
Dirk Richter1, Bernd Eikelmann, Klaus Berger
1Westphalian Clinic for Psychiatry and Psychotherapy, Muenster, Germany. d.richter@wkp-muenster.de
Objective:
The aim of this study was to analyse whether the SF-36 questionnaire is a useful tool to evaluate the treatment outcome of a drug detoxification program.
Methods:
A pre post assessment of consecutive referrals to a drug detoxification program of a psychiatric state hospital in north-western Germany was conducted. Seventy-nine males and twenty-one females with a diagnosis of multiple substance use were included. MOS short form 36 (SF-36) was used upon admission and discharge to assess changes in self-perceived health status. Severity scales from the addiction severity interview (ASI) were used to rate severity of illness by a physician at program entry.
Results:
Patients with severe comorbidity (hepatitis B, depression, attempted suicide) reported significant worse health states, compared to those without. Positive correlations between physician rated addiction severity and patients' self-perceived health status were observed, most strongly for mental health status. For the 48 patients with 2 assessments significant improvements during the treatment period were observed on SF-36 subscales 'general health' and 'physical functioning'. Patients with severe physical and/or mental problems upon admission had more benefits from treatment than patients without.
Conclusions:
SF-36 questionnaire is a useful instrument to monitor the health status and to evaluate treatment effects in drug addicts.
More Related Videos
10:17High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
Published on: April 23, 2019
09:16A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
Published on: January 22, 2016